TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease
Condition(s) studied
Study summary
Porto-sinusoidal Vascular Disease (PSVD) is characterized by a portal hypertension (PH) without cirrhosis. This can induce PH complications, like digestive hemorrhage from esophageal or gastric varices, ascites, or even portal thrombosis. Due to the rarity of MVPS, the treatment of complications of portal hypertension is modeled on the methods used in cirrhotic portal hypertension with non-cardio-selective beta blockers, endoscopic ligations or diuretics in first line therapy, as proposed by the Baveno VII recommendations. In complicated or refractory forms of PH in PSVD, the place of TIPS is also discussed, as in the field of cirrhosis. However, the experience of TIPS in PSVD is limited, reported in case reports and small specifically dedicated series. No predictive factors for survival or recurrence and tolerance were well known. A larger study with control group is needed in order to better know the right time and the right indication for the use of TIPS in complicated PH PSVD-related.
The study will be retrospective, multicentric involving tertiary university French centers, expert in the management of TIPS. Patients white TIPS-PSVD will be compared with historical patients with TIPS-cirrhose, matched on age, sexe, indication of TIPS. The study will not comprise new intervention, only observational in a real life condition
Eligibility
Primary outcome measure(s)
- overall survival after TIPS placement — at 3 months
- overall survival after TIPS placement — at 6 months
- overall survival after TIPS placement — at 1 year
- overall survival after TIPS placement — at 2 years
- overall survival after TIPS placement — at 3 years
- overall survival after TIPS placement — at 4 years
- overall survival after TIPS placement — at 5 years
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU Amiens Picardie | Amiens | Picardie | Recruiting |
More Centre Hospitalier Universitaire, Amiens trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07163689 on ClinicalTrials.gov ↗ ← All trials in France